NASDAQ: RNAAtrium Therapeutics Inc Stock Ownership - Who owns Atrium Therapeutics?
Insider buying vs selling
Have Atrium Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when RNA insiders and whales buy or sell their stock.
RNA Shareholders
What type of owners hold Atrium Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 3.66% | 626,869 | $8.32M | Institution |
| Vanguard Portfolio Management LLC | 2.01% | 344,369 | $4.57M | Institution |
| Sarah Boyce | 1.55% | 265,086 | $3.52M | Insider |
| Arbiter Partners Capital Management LLC | 1.34% | 230,000 | $3.05M | Institution |
| Kathleen P. Gallagher | 0.77% | 131,361 | $1.74M | Insider |
| Td Asset Management Inc | 0.65% | 111,200 | $1.48M | Institution |
| Vanguard Fiduciary Trust Co | 0.56% | 95,128 | $1.26M | Institution |
| Steven George Hughes | 0.43% | 73,097 | $970.00k | Insider |
| W. Michael Flanagan | 0.32% | 54,786 | $727.01k | Insider |
| Husam Younis | 0.31% | 52,657 | $698.76k | Insider |
RNA vs Biotech Stocks
Atrium Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.